CDKN2D-WDFY2 Is a Cancer-Specific Fusion Gene Recurrent in High-Grade Serous Ovarian Carcinoma

• Kalpana Kannan ,

  Contributed equally to this work with: Kalpana Kannan, Cristian Coarfa

  Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Cristian Coarfa ,

  Contributed equally to this work with: Kalpana Kannan, Cristian Coarfa

  Affiliation Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Kimal Rajapakshe,

  Affiliation Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Shannon M. Hawkins,

  Affiliation Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Martin M. Matzuk,

  Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pharmacology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Aleksandar Milosavljevic,

  Affiliation Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Laising Yen

  * E-mail: yen@bcm.edu

  Affiliations Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America, Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯